Top compounds associated with response to SPRY2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA AZ628 GDSC1000 pan-cancer AAC 0.3 1e-08
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA SB590885 GDSC1000 pan-cancer AAC 0.16 8e-06
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.16 2e-05
mRNA PLX4720 CCLE pan-cancer AAC 0.21 2e-05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV